Literature DB >> 26562024

Identification of BRAF Kinase Domain Duplications Across Multiple Tumor Types and Response to RAF Inhibitor Therapy.

Samuel J Klempner1, Rodolfo Bordoni2, Kyle Gowen3, Henry Kaplan4, Philip J Stephens5, Sai-Hong Ignatius Ou1, Siraj M Ali3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26562024     DOI： 10.1001/jamaoncol.2015.4437

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  12 in total

1.  Double Trouble: Kinase domain duplication as a new path to drug resistance.

Authors:  Hsin-Yi Chen; Donita C Brady; Jessie Villanueva
Journal:  Pigment Cell Melanoma Res       Date:  2016-09       Impact factor: 4.693

2.  BRAF internal deletions and resistance to BRAF/MEK inhibitor therapy.

Authors:  Douglas B Johnson; Merrida A Childress; Zachary R Chalmers; Garrett M Frampton; Siraj M Ali; Samuel M Rubinstein; David Fabrizio; Jeffrey S Ross; Sohail Balasubramanian; Vincent A Miller; Philip J Stephens; Jeffrey A Sosman; Christine M Lovly
Journal:  Pigment Cell Melanoma Res       Date:  2017-12-16       Impact factor: 4.693

Review 3.  Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment.

Authors:  Masato Nakaguro; Yuichiro Tada; William C Faquin; Peter M Sadow; Lori J Wirth; Toshitaka Nagao
Journal:  Cancer Cytopathol       Date:  2020-05-18       Impact factor: 5.284

4.  Moving molecular subtypes to the clinic in gastric cancer.

Authors:  Joseph Chao; Jeeyun Lee; Samuel J Klempner
Journal:  Transl Cancer Res       Date:  2016-06       Impact factor: 1.241

5.  BRAF in Lung Cancers: Analysis of Patient Cases Reveals Recurrent BRAF Mutations, Fusions, Kinase Duplications, and Concurrent Alterations.

Authors:  Yuri Sheikine; Dean Pavlick; Samuel J Klempner; Sally E Trabucco; Jon H Chung; Mark Rosenzweig; Kai Wang; Vamsidhar Velcheti; Garrett M Frampton; Nir Peled; Molly Murray; Young Kwang Chae; Lee A Albacker; Laurie Gay; Hatim Husain; James H Suh; Sherri Z Millis; Venkataprasanth P Reddy; Julia A Elvin; Ryan J Hartmaier; Afshin Dowlati; Phil Stephens; Jeffrey S Ross; Trever G Bivona; Vincent A Miller; Shridar Ganesan; Alexa B Schrock; Sai-Hong Ignatius Ou; Siraj M Ali
Journal:  JCO Precis Oncol       Date:  2018-04-19

6.  Plasticity of Extrachromosomal and Intrachromosomal BRAF Amplifications in Overcoming Targeted Therapy Dosage Challenges.

Authors:  Kai Song; Jenna K Minami; Arthur Huang; Siavash R Dehkordi; Shirley H Lomeli; Jens Luebeck; Mark H Goodman; Gatien Moriceau; Oscar Krijgsman; Prashanthi Dharanipragada; Trevor Ridgley; William P Crosson; Jesus Salazar; Eli Pazol; Gabriel Karin; Rachana Jayaraman; Nikolas G Balanis; Salwan Alhani; Kyle Sheu; Johanna Ten Hoeve; Amelia Palermo; Stephen E Motika; T Niroshi Senaratne; Kim H Paraiso; Paul J Hergenrother; P Nagesh Rao; Asha S Multani; Daniel S Peeper; Vineet Bafna; Roger S Lo; Thomas G Graeber
Journal:  Cancer Discov       Date:  2022-04-01       Impact factor: 38.272

7.  Spectrum of BRAF Mutations and Gene Rearrangements in Ovarian Serous Carcinoma.

Authors:  M Herman Chui; Jason C Chang; Yanming Zhang; Ahmet Zehir; Alison M Schram; Jason Konner; Alexander E Drilon; Arnaud Da Cruz Paula; Britta Weigelt; Rachel N Grisham
Journal:  JCO Precis Oncol       Date:  2021-09-16

8.  Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer: trials and treatment options.

Authors:  Arpita Desai; Smitha P Menon; Grace K Dy
Journal:  Cancer Biol Med       Date:  2016-03       Impact factor: 4.248

9.  Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies.

Authors:  J S Ross; L M Gay; K Wang; J A Vergilio; J Suh; S Ramkissoon; H Somerset; J M Johnson; J Russell; S Ali; A B Schrock; D Fabrizio; G Frampton; V Miller; P J Stephens; J A Elvin; D W Bowles
Journal:  Ann Oncol       Date:  2017-10-01       Impact factor: 32.976

Review 10.  Mechanisms of receptor tyrosine kinase activation in cancer.

Authors:  Zhenfang Du; Christine M Lovly
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.